<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="https://www.limsforum.com/styles/rss.xsl" ?><?xml-stylesheet type="text/css" href="https://www.limsforum.com/styles/rss.css" ?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Multinational Biopharmaceutical Company Licenses LabVantage&#8217;s Sapphire&#8482; To Support Its Core Biomaterial Research for Cancer and Immunological Therapies	</title>
	<atom:link href="https://www.limsforum.com/multinational-biopharmaceutical-company-licenses-labvantages-sapphire-to-support-its-core-biomaterial-research-for-cancer-and-immunological-therapies/51340/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.limsforum.com/multinational-biopharmaceutical-company-licenses-labvantages-sapphire-to-support-its-core-biomaterial-research-for-cancer-and-immunological-therapies/51340/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=multinational-biopharmaceutical-company-licenses-labvantages-sapphire-to-support-its-core-biomaterial-research-for-cancer-and-immunological-therapies</link>
	<description>The Global Laboratory, Informatics, Medical and Science Professional Community</description>
	<lastBuildDate>Wed, 05 Sep 2007 22:38:23 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.1.10</generator>
</channel>
</rss>
